Interleukin 38 Protects Against Lethal Sepsis
Clicks: 40
ID: 273864
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
11.7
/100
40 views
6 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #214 of 431 articles by views in The Journal of infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 431 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This study demonstrated that interleukin 38 (IL-38) release occurred in clinical and experimental sepsis and that IL-38 treatment could improve survival in expe
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (22 words).
Try re-searching for a better abstract.
| Reference Key |
fang2018theinterleukin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Xu, Fang;Lin, Shihui;Yan, Xingxing;Wang, Chuanjiang;Tu, Hongmei;Yin, Yibing;Cao, Ju; |
| Journal | The Journal of infectious diseases |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.